INZY
Inozyme Pharma
INZY
INZY
Delisted
INZY was delisted on the 30th of June, 2025.
86 hedge funds and large institutions have $202M invested in Inozyme Pharma in 2025 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 9 increasing their positions, 29 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
less funds holding
Funds holding: →
23% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 47
69% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 29
Holders
86
Holding in Top 10
3
Calls
$827K
Puts
–
Top Buyers
| 1 | +$25.3M | |
| 2 | +$17.3M | |
| 3 | +$12.8M | |
| 4 |
TC
Trium Capital
London,
United Kingdom
|
+$12.7M |
| 5 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$8.75M |
Top Sellers
| 1 | -$8.47M | |
| 2 | -$4.7M | |
| 3 | -$4.63M | |
| 4 |
BlackRock
New York
|
-$4.33M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$3.14M |
